Medplus Health subsidiary receives drug license suspension order
Medplus Health Services announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a Drug License for a store located in Andhra Pradesh. This regulatory action falls under SEBI guidelines concerning listing obligations and disclosure requirements. The suspension, effective from July 9, 2025, was issued by the Assistant Director and sales licensing authority in Andhra Pradesh. The suspension order pertains to a store situated at Nippo centre, Andhra Pradesh, and involves a temporary cessation of drug sales activities. The company estimates the potential revenue loss due to the seven-day suspension to be approximately INR~3.40lacs.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Medplus Health Services publishes news
Free account required • Unsubscribe anytime